Published in Neoplasia on September 25, 2001
Decoy receptor 3 is a prognostic factor in renal cell cancer. Neoplasia (2008) 1.33
Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer. Clin Cancer Res (2010) 1.22
Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas. J Natl Cancer Inst (2009) 1.19
Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein. Am J Pathol (2006) 1.16
Clusterin and chemoresistance. Adv Cancer Res (2009) 1.14
Update on options for treatment of metastatic castration-resistant prostate cancer. Onco Targets Ther (2010) 1.00
Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. J Exp Clin Cancer Res (2012) 0.89
The role of stress proteins in prostate cancer. Curr Genomics (2007) 0.88
Clusterin confers gemcitabine resistance in pancreatic cancer. World J Surg Oncol (2011) 0.88
Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model. Br J Cancer (2012) 0.88
Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Neoplasia (2005) 0.82
Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer. Biochim Biophys Acta (2007) 0.82
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity. Breast Cancer Res (2007) 0.80
Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen. Cancer Med (2013) 0.80
Clusterin immunoexpression and its clinical significance in patients with non-small cell lung cancer. Lung (2010) 0.80
eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells. Oncotarget (2016) 0.79
Effects of female sex hormones on clusterin expression and paclitaxel resistance in endometrial cancer cell lines. Int J Med Sci (2011) 0.76
New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids. Acta Naturae (2009) 0.75
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Renal-cell carcinoma. N Engl J Med (1996) 11.46
Paclitaxel (taxol) N Engl J Med (1995) 5.79
Systemic therapy for renal cell carcinoma. J Urol (2000) 2.89
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. N Engl J Med (1998) 2.85
Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med (1996) 2.39
Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem (1999) 1.98
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res (1991) 1.87
Chemotherapy for advanced renal-cell carcinoma: 1983-1993. Semin Oncol (1995) 1.83
Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J Natl Cancer Inst (1997) 1.78
Epidemiologic aspects of renal cell cancer. Semin Oncol (2000) 1.77
Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol (1995) 1.73
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst (1999) 1.71
Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem (1983) 1.64
Therapeutic applications of oligonucleotides. Annu Rev Pharmacol Toxicol (1992) 1.64
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat Med (1998) 1.50
Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res (2000) 1.35
Hormonal therapy and chemotherapy of renal-cell carcinoma. Semin Oncol (1983) 1.11
Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides. J Natl Cancer Inst (2000) 1.10
Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J Cancer Res Clin Oncol (1994) 1.08
Immunotherapy for metastatic renal cell carcinoma. Urol Clin North Am (1993) 1.07
Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model. Cancer Res (1999) 1.03
Expression of clusterin in human renal diseases. Kidney Int (1994) 0.99
Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Oncogene (1998) 0.98
Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin Cancer Res (2000) 0.94
Clusterin and the kidney. Exp Nephrol (1995) 0.93
Clusterin: an enigmatic protein recruited by diverse stimuli. J Lab Clin Med (1993) 0.92
In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides. Cancer Res (1996) 0.89
Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors. Prostate (2000) 0.83
Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice. Clin Cancer Res (1997) 0.81
Growth inhibition of DU-145 prostate cancer cells by a Bcl-2 antisense oligonucleotide is enhanced by N-(2-hydroxyphenyl)all-trans retinamide. Br J Cancer (1998) 0.80
Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines. Aliment Pharmacol Ther (2013) 3.32
Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer (1994) 3.25
Comparison of time-resolved and -unresolved measurements of deoxyhemoglobin in brain. Proc Natl Acad Sci U S A (1988) 3.01
Post-replicative base excision repair in replication foci. EMBO J (1999) 2.86
Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med (1998) 2.72
The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.30
Sequence variation in the 18S rRNA gene, a target for PCR-based malaria diagnosis, in Plasmodium ovale from southern Vietnam. J Clin Microbiol (1996) 2.12
Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer. J Urol (2004) 1.73
Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement. BJU Int (2002) 1.69
Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer (1998) 1.65
Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg (2003) 1.62
Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model. J Steroid Biochem Mol Biol (1996) 1.61
Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol (1996) 1.53
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report. Urology (1995) 1.50
Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer (2005) 1.49
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol (1995) 1.44
Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res (2000) 1.41
In situ replacement of the aorta in a contaminated field with the infrarenal inferior vena cava. J Vasc Surg (1999) 1.39
Transient anisocoria after intravenous administration of butylscopolamine. Anesth Analg (1991) 1.39
Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem (1997) 1.38
Radiation exposure to anaesthetists during endovascular procedures. Anaesthesia (2014) 1.38
Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res (2000) 1.35
Uneven fatty replacement of the pancreas: evaluation with CT. Radiology (1995) 1.30
Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg (1999) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Species-specific PCR detection of malaria parasites by microtiter plate hybridization: clinical study with malaria patients. J Clin Microbiol (1995) 1.21
Changing state of gallstone disease in Japan. Composition of the stones and treatment of the condition. Am J Surg (1970) 1.18
Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observations. Mol Urol (2000) 1.17
The contribution of founder mutations to early-onset breast cancer in French-Canadian women. Clin Genet (2009) 1.17
Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012. Chem Biol (1994) 1.16
Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. Endocrinology (2000) 1.13
Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2'-O-(2-methoxy)ethyl chemistry. J Pharmacol Exp Ther (2001) 1.12
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
Congenital malformations and childhood cancer. Med Pediatr Oncol (2000) 1.11
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Lifestyle and gastric cancer: a case-control study. Oncol Rep (1998) 1.11
Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis. Circ Res (2001) 1.10
Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides. J Natl Cancer Inst (2000) 1.10
Renal antioxidant enzymes: their regulation and function. Kidney Int (1994) 1.09
Properties and functions of human uracil-DNA glycosylase from the UNG gene. Prog Nucleic Acid Res Mol Biol (2001) 1.09
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. Acta Neurol Scand (2008) 1.08
A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res (1997) 1.08
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline. Cancer Res (1993) 1.05
A non-toxic heat shock protein 70 inducer, geranylgeranylacetone, suppresses apoptosis of cultured rat hepatocytes caused by hydrogen peroxide and ethanol. J Hepatol (2001) 1.05
Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin Cancer Res (2001) 1.05
Angiographic examination and surgical treatment of bow hunter's stroke. Neurosurgery (1988) 1.05
Structural requirement of leucine for activation of p70 S6 kinase. FEBS Lett (1999) 1.05
Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. Clin Cancer Res (1999) 1.05
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells. Cancer Res (2000) 1.04
Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model. Cancer Res (1999) 1.03
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Observation of anomalous upsilon(1S)pi+pi(-) and upsilon(2S)pi+pi(-) production near the upsilon(5S) resonance. Phys Rev Lett (2008) 1.02
Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs. J Natl Cancer Inst (1998) 1.01
Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888. Br J Pharmacol (1992) 1.01
[A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers]. Gan To Kagaku Ryoho (1992) 1.01
A case-control study of non-T cell acute lymphoblastic leukaemia of children in Hokkaido, Japan. J Epidemiol Community Health (1989) 1.01
Case-control study of ovarian cancer in Japan. Cancer (1984) 1.01
Clinical course and prognosis of chronic pancreatitis. Pancreas (1987) 1.00
Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology (1999) 1.00
Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int (1995) 1.00
Body fat distribution and uterine leiomyomas. J Epidemiol (1998) 1.00
Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol (1988) 0.99
Effects of the mass screening of neuroblastoma in Sapporo City. Cancer (1987) 0.99
GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer. Oncogene (2012) 0.98
Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem Suppl (1992) 0.98
Pulmonary artery involvement as first manifestation in three cases of Takayasu arteritis. Int J Cardiol (1996) 0.97
Sequence variation in the human uracil-DNA glycosylase (UNG) gene. Mutat Res (2001) 0.97
Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1. AIDS Res Hum Retroviruses (2000) 0.97
Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97
Dose-response relationship between coffee and the risk of pancreas cancer. Jpn J Clin Oncol (1996) 0.96
Posture-related changes in the pressure environment of the ventriculoperitoneal shunt system. J Neurosurg (2000) 0.96
Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo. Jpn J Cancer Res (2001) 0.95
Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder. Jpn J Clin Oncol (2001) 0.95
Role of percutaneous image-guided biopsy in the evaluation of renal masses. Urol Int (2001) 0.95
Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient? Br J Urol (1998) 0.95
Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin Cancer Res (2000) 0.94
Inflammatory pseudotumor of the urinary bladder: a report of five cases and review of the literature. Can J Urol (2001) 0.94
Identification of a novel human homolog of the Drosophila dlg, P-dlg, specifically expressed in the gland tissues and interacting with p55. FEBS Lett (1998) 0.94
Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res (1998) 0.93
Effect of late evening snack with rice ball on energy metabolism in liver cirrhosis. Eur J Clin Nutr (2006) 0.93
A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer. Clin Cancer Res (2001) 0.93
Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction. Clin Nephrol (2000) 0.93
Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model. BJU Int (2003) 0.92
Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch. Cell Death Differ (2011) 0.92
Search for a fermiophobic Higgs boson decaying into diphotons in pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.92
Increased aspartate and glutamate levels in both gastric and colon cancer tissues. Tokushima J Exp Med (1993) 0.91
First measurement of the b-jet cross section in events with a W boson in pp collisions at square root(s) = 1.96 TeV. Phys Rev Lett (2010) 0.91
Fertility and uterine size among Asian women undergoing hysterectomy for leiomyomas. Int J Fertil Womens Med (2000) 0.91
Studies on peptides. CXIII. Synthesis of the heptacosapeptide amide corresponding to the entire amino acid sequence of chicken secretin. Int J Pept Protein Res (1984) 0.91